The arc of biotechnology is one of breakthroughs and struggles, writes Tim Hunt, CEO of the Alliance for Regenerative ...

According to the report, titled "India Bioeconomy Report 2025", the bioeconomy sector witnessed a 16-fold expansion in the ...

Both companies saw their shares rise significantly; the former had exciting clinical progress, while the latter signed a lucrative deal with a biotech giant that had Wall Street cheering.

Supreme Court hearings on GM crops progress, DBT supports GM mustard, BioE3 policy focus, bio-agriculture growth in India.

PASADENA, Calif, March 27, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings ... “Continued progress has been made in collaborative clinical studies with two global pharmaceutical companies ...

their progress, enrollment or results, or the company’s financial position or cash runway, are based on IO Biotech’s current assumptions and expectations of future events and trends ...

ONP-002 Advances Toward Phase IIa Concussion Trial with Strengthened Financial Foundation and Industry MomentumSARASOTA, Fla.

(RTTNews) - LIXTE Biotechnology Holdings, Inc. (LIXT), on Thursday, announced the latest progress with its proprietary compound, LB-100, for the treatment of ovarian and colorectal cancer.

“Continued progress has been made in collaborative ... and make them more vulnerable for immunotherapy. About LIXTE Biotechnology Holdings, Inc. This announcement contains certain forward ...

PASADENA, Calif, March 27, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. ("LIXTE” or the "Company”) (Nasdaq: ...